1. 200 Efficacy and safety of belimumab in patients of black race with systemic lupus erythematosus: results from the EMBRACE study. (April 2019) Authors: D'Cruz, David; Maksimowicz-McKinnon, Kathleen; Oates, Jim; Santiago, Mittermayer Barreto; Bass, Damon; Burriss, Susan; Gilbride, Jennifer; Groark, James; Miller, Michelle; Ji, Beulah Journal: Lupus science & medicine Issue: Volume 6(2019)supplement 1 Page Start: A149 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Efficacy and Safety of Belimumab and Azathioprine for Maintenance of Remission in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis: A Randomized Controlled Study. Issue 6 (16th April 2019) Authors: Jayne, David; Blockmans, Daniel; Luqmani, Raashid; Moiseev, Sergey; Ji, Beulah; Green, Yulia; Hall, Leanne; Roth, David; Henderson, Robert B.; Merkel, Peter A. Other Names: Lozano Jose Alfaro investigator.; Becker Heidemarie investigator.; Quiroz Armando Calvo investigator.; Carette Simon investigator.; Carrillo‐Vazquez Sandra investigator.; Cid María C. investigator.; D'Cruz David investigator.; Deodhar Atul investigator.; Flossman Oliver investigator.; Garibotto G... Journal: Arthritis & rheumatology Issue: Volume 71:Issue 6(2019) Page Start: 952 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Efficacy and Safety of Belimumab and Azathioprine for Maintenance of Remission in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis: A Randomized Controlled Study. Issue 6 (16th April 2019) Authors: Jayne, David; Blockmans, Daniel; Luqmani, Raashid; Moiseev, Sergey; Ji, Beulah; Green, Yulia; Hall, Leanne; Roth, David; Henderson, Robert B.; Merkel, Peter A. Other Names: Lozano Jose Alfaro investigator.; Becker Heidemarie investigator.; Quiroz Armando Calvo investigator.; Carette Simon investigator.; Carrillo‐Vazquez Sandra investigator.; Cid María C. investigator.; D'Cruz David investigator.; Deodhar Atul investigator.; Flossman Oliver investigator.; Garibotto G... Journal: Arthritis & rheumatology Issue: Volume 71:Issue 6(2019) Page Start: 952 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Efficacy and Safety of Belimumab and Azathioprine for Maintenance of Remission in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis: A Randomized Controlled Study. Issue 6 (16th April 2019) Authors: Jayne, David; Blockmans, Daniel; Luqmani, Raashid; Moiseev, Sergey; Ji, Beulah; Green, Yulia; Hall, Leanne; Roth, David; Henderson, Robert B.; Merkel, Peter A. Other Names: Lozano Jose Alfaro investigator.; Becker Heidemarie investigator.; Quiroz Armando Calvo investigator.; Carette Simon investigator.; Carrillo‐Vazquez Sandra investigator.; Cid María C. investigator.; D'Cruz David investigator.; Deodhar Atul investigator.; Flossman Oliver investigator.; Garibotto G... Journal: Arthritis & rheumatology Issue: Volume 71:Issue 6(2019) Page Start: 952 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Efficacy and safety of intravenous belimumab in Japanese patients with systemic lupus erythematosus: A subgroup analysis of a phase 3 randomized placebo-controlled trial. Issue 3 (4th May 2019) Authors: Tanaka, Yoshiya; Bass, Damon; Chu, Myron; Egginton, Sally; Ji, Beulah; Struemper, Herbert; Roth, David Journal: Modern rheumatology Issue: Volume 29:Issue 3(2019) Page Start: 452 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. FRI0181 THE PLUTO STUDY: INTRAVENOUS BELIMUMAB IN CHILDREN WITH SYSTEMIC LUPUS ERYTHEMATOSUS. (June 2019) Authors: Ruperto, Nicolino; Abud-Mendoza, Carlos; Viola, Diego O.; Calvo, Inmaculada; Levy, Deborah M.; Gallegos, Julia Calderon; Ferrandiz, Manuel; Chasnyk, Vyacheslav; Keltsev, Vladimir; Anton, Jordi; Gastanaga, Maria; Shishov, Michael; Boteanu, Alina; Henrickson, Michael; Bass, Damon; Clark, Ken; Hamme... Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 2 Page Start: 764 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Investigation of the Clinical, Radiological and Biological Factors Associated with Disease Progression, Phenotypes and Endotypes of COPD in China (COMPASS): study design, protocol and rationale. Issue 3 (13th September 2021) Authors: Liang, Zhenyu; Zhong, Nanshan; Chen, Rongchang; Ma, Qianli; Sun, Yongchang; Wen, Fuqiang; Tal-Singer, Ruth; Miller, Bruce E.; Yates, Julie; Song, Jie; Compton, Chris; Ji, Beulah; Wu, Li; Yang, Yang; Jones, Paul; Zheng, Jinping Journal: ERJ open research Issue: Volume 7:Issue 3(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. LB0012 HEADLINE RESULTS FOR A PHASE 4, 52-WEEK, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS ADVERSE EVENTS OF SPECIAL INTEREST (AESI) IN ADULTS WITH ACTIVE, AUTOANTIBODY-POSITIVE SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) RECEIVING BELIMUMAB. (June 2019) Authors: Sheikh, Saira; Scheinberg, Morton; Cheng-Chung Wei, James; Tegzova, Dana; Stohl, William; Mucenic, Tamara; Levy, Roger; Bass, Damon; Ross Terrés, Jorge; Punwaney, Rajesh; Harris, Julia; Thorneloe, Kevin; Ji, Beulah; Roth, David Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 2 Page Start: 266 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. LB001EFFICACY AND SAFETY OF BELIMUMAB IN PATIENTS WITH ACTIVE LUPUS NEPHRITIS: A PHASE 3, RANDOMISED, PLACEBO-CONTROLLED TRIAL. (7th June 2020) Authors: Rovin, Brad; Houssiau, Frédéric A; Furie, Richard; Malvar, Ana; Teng, Y K O; Mok, Chi Chiu; Contreras, Gabriel; Yu, Xueqing; Dolff, Sebastian; Ji, Beulah; Roth, David; Kleoudis, Christi; Bass, Damon; Madan, Anuradha; Wright, Amanda; Barnett, Carly; Green, Yulia Journal: Nephrology dialysis transplantation Issue: Volume 35(2020)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Long-term open-label continuation study of the safety and efficacy of belimumab for up to 7 years in patients with systemic lupus erythematosus from Japan and South Korea. Issue 2 (2nd July 2021) Authors: Tanaka, Yoshiya; Bae, Sang-Cheol; Bass, Damon; Curtis, Paula; Chu, Myron; DeRose, Kathleen; Ji, Beulah; Kurrasch, Regina; Lowe, Jenny; Meizlik, Paige; Roth, David A Journal: RMD open Issue: Volume 7:Issue 2(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗